Semaglutide, marketed under brand names like Wegovy and Ozempic, is approved for chronic weight management in adults who meet specific criteria
& Roy, I
By comparison with the chitosan control, the pheomelanin sample shows a paired amplification of reduction currents in region D and oxidation currents in region C
The search included studies with results available up to June 10, 2025, and was restricted to completed trial records and full-text articles available in English
Glucagon-like peptide-1 (GLP-1) receptor agonists, including semaglutide (Ozempic, Wegovy), dulaglutide (Trulicity), and liraglutide (Victoza, Saxenda), are increasingly prescribed for type 2 diabetes management and weight loss
Animal studies show potential risks to fetal development, and there is insufficient human data to determine safety